The application of artificial intelligence in the medical field is transitioning from "auxiliary tools" to "autonomous decision-makers". Since 2026, multiple institutions have made breakthrough progress in AI assisted diagnosis, drug development, and surgical robots, redefining the boundaries of modern healthcare.
In terms of medical imaging diagnosis, the accuracy of AI has reached or even surpassed that of senior radiologists. The latest multimodal AI model can simultaneously analyze CT, MRI, and pathological sections to comprehensively determine the benign or malignant nature of lesions. A clinical study involving 50000 patients at Peking Union Medical College Hospital showed that AI assistance increased the detection rate of early lung cancer by 23% and reduced misdiagnosis rates by 15%. AI not only looks more accurately, but also faster - the analysis time for a single image has been reduced from 3-5 minutes for doctors to 3-5 seconds for AI.
The field of drug development is also experiencing AI driven acceleration. The average development time for traditional new drugs is 10-15 years, with an investment of over 1 billion US dollars. AI can screen candidate compounds from millions of molecules within weeks and shorten preclinical research cycles by over 60%. DeepMind's AlphaFold series has predicted over 200 million protein structures, providing unprecedented foundational data for targeted drug design.
Surgical robots have also become smarter with the empowerment of AI. The new generation of AI surgical robots can not only execute predetermined operation paths, but also recognize tissue types through real-time visual analysis, avoid important blood vessels, and even autonomously adjust strategies during surgery to respond to emergencies. The next generation product of Da Vinci System has deeply integrated the AI decision-making module, achieving a closed-loop of "perception analysis execution".
Of course, AI's autonomous decision-making in the healthcare field has also sparked discussions on regulation and ethics - who is responsible for AI's diagnostic errors? Is the decision-making process of AI transparent and explainable? These issues need to be addressed at the institutional level alongside technological development.